Clinical data were collected through medical chart reviews and ... greater than 1%. Tumor staging prior to treatment was determined according to the guidelines of the 8th edition of the American Joint ...

General practitioners (GPs) may soon be able to identify patients with an increased risk of lung cancer up to four months ...

Dr. Douglas Reznick shares advice for patients with lung or head and neck cancer who may feel overwhelmed by their diagnosis.

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Although immunotherapies and biomarker-driven interventions have transformed lung cancer outcomes, Martin Edelman, MD, Fox Chase Cancer Center, highlighted the present challenge hindering clinicians' ...

Many factors can increase your risk of lung cancer. Some are controllable, like smoking, while others aren’t, like your medical history. Knowing the controllable risk factors might help you ...

One in 3,000 People at Risk of Punctured Lung ... cancer and shown that these allow immunotherapies to target non-responsive ... Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage ...

GPs may soon be able to identify patients with an increased risk of lung cancer up to 4 months earlier than is currently the case.

is not included in American Joint Commission on Cancer (AJCC) staging. This study addressed this deficiency by including responses to therapy with standardized staging variables in a validated ...

Your chances depend on what type of lung cancer you have and its stage. The kind of treatment you’ve had may also play a role. There are two types of lung cancer: Non-small-cell lung cancer ...